COVID-19

The Complete Diagnostic Workflow

The Outbreak | In December 2019, an outbreak of respiratory illness started in Wuhan City, Hubei Province, China and has now spread throughout the world to many different countries. This respiratory disease was caused by a novel coronavirus and was initially termed “2019 novel coronavirus” or “2019-nCoV”, however in February of 2020 the World Health Organization (WHO) announced that the official name of the disease is COVID-19. The official name of the coronavirus causing COVID-19 is SARS-CoV-2...Continue Reading

For more resources about 2019 Novel Coronavirus (COVID-19), visit the following links:

Centres for Disease Control and Prevention (CDC)
World Health Organization (WHO)

Always ready to do our part.

COVID-19 TaqMan RT-PCR Kit (E/RdRP genes)

Introducing Norgen's multiplex PCR detection solutions for COVID-19 based on
the Charité/Berlin protocol recommended by the WHO for the detection of COVID-19.
CE-IVD Approval Pending

2019-nCoV TaqMan RT-PCR Kit

Norgen's PCR detection solutions for COVID-19 is based on
the protocol and RT-PCR panel published by the CDC for the detection of COVID-19. For single reactions
CE-IVD Approval Pending


Instructions from CDC | CDC Primer and Probes

Sample Collection | RNA Isolation | PCR Based Detection

View our complete diagnostic workflow

TM67200
COVID-19 TaqMan RT-PCR Kit (E/RdRP genes)  
For Multiplex Reactions

  • Contains WHO recommended primers/probes based the Charité/Berlin protocol; E/RdRp genes
  • Detection kit for SARS-CoV-2, which causes COVID-19 (2019-nCoV)
  • Ready-to-use format containing everything required for detection

Ordering information 

TM67100, TM67120
2019-nCoV TaqMan RT-PCR Kit
For Single Reactions

  • Detection kit for SARS-CoV-2, which causes COVID-19
    (2019-nCoV)
  • Ready to use format containing everything required for detection
  • Available in 2 sizes: 50 reactions and 500 reactions

Ordering information 


COVID-19 Complete Workflow Solution

Recommended Products and Add-ons


Ideal for use with in vitro diagnostic workflows

Use Cat. No Description Available Sizes Regulatory
1. Sample Collection & Preservation Dx69200 Total Nucleic Acid Preservation Tubes Dx  50 Units CE-IVD
53800 Saliva RNA Collection and Preservation Devices Dx  50 Devices CE-IVD
2. RNA Isolation Dx69100 Saliva / Swab RNA Purification Kit Dx   50 Preps CE-IVD
Dx69300 Saliva / Swab RNA Purification 96-Well Kit Dx   2 x 96-Well Plates CE-IVD
Dx17200 Total RNA Purification Kit Dx 50 Preps CE-IVD
3. PCR based detection DxTM67200 COVID-19 TaqMan RT-PCR Kit (E/RdRP genes) Dx 500 reactions CE-IVD pending
DxTM67100 2019-nCoV TaqMan RT-PCR Kit Dx 50 reactions, 500 reactions CE-IVD pending

 

For research use only. Not for in vitro diagnostic use.

Use Cat. No Description Available Sizes
1. Sample Collection & Preservation 69200 Total Nucleic Acid Preservation Tubes 50 tubes
RU53800 Saliva RNA Collection and Preservation Device 50 Devices
2. RNA Isolation 69100 Saliva/Swab RNA Purification Kit 50 Preps
69300 Saliva/Swab RNA Purification 96-Well Kit 2 x 96-well plates
17200
37500
17250
17270
Total RNA Purification Kit 50 Preps
100 Preps
250 preps
500 preps
24300
24350
24370
24380
Total RNA Purification 96-Well Kit 2 x 96-well plates
6 x 96-well plates
3. PCR based detection TM67200 COVID-19 TaqMan RT-PCR Kit (E/RdRP genes) 500 reactions
TM67100
TM67120
2019-nCoV TaqMan RT-PCR Kit 50 reactions, 500 reactions
4. Components and add-ons TM67101*
TM67130*
2019-nCoV Primer & Probe Mixes 50 reactions, 500 reactions
PC67102**
PC67120**
2019-nCoV RT-PCR Positive Control 50 reactions, 500 reactions (per tube)
28113
28115
2X One-Step RT-PCR Master Mix 100 reactions, 500 reactions

* This kit includes all 3 assays in individual tubes, which are premixed to the working concentrations recommended by the CDC
** The control plasmid contains the CDC 2019-nCoV markers (N1,N2) and RNase P gene which are compatible with the CDC COVID-19 specific primer/probe sets


Norgen Biotek is not an endorsed supplier of the CDC coronavirus RT-PCR panel or positive controls. Norgen is offering these products based on the sequences that were published by the CDC, and these are being offered to our customers for research use only, not for in vitro diagnostic use

Coronavirus Disease 2019 (COVID-19)

In December 2019, an outbreak of respiratory illness started in Wuhan City, Hubei Province, China and has now spread throughout the world to many different countries. This respiratory disease was caused by a novel coronavirus and was initially termed “2019 novel coronavirus” or “2019-nCoV”, however in February of 2020 the World Health Organization (WHO) announced that the official name of the disease is COVID-19. The official name of the coronavirus causing COVID-19 is SARS-CoV-2.

Coronaviruses are a large family of viruses known to infect both animals and humans. SARS-CoV-2 is a new strain of coronavirus infecting h umans that had not been previously detected before the outbreak in China in December 2019. While the SARS-CoV-2 is new, many coronaviruses have been known to infect animals and humans for some time. Coronaviruses are known to commonly infect camels, cattle, cats, and bats. In humans, Coronavirus infections can cause various illnesses from the common cold to more severe diseases such as Middle East Respiratory Syndrome (MERS) and Severe Acute Respiratory Syndrome (SARS).

Human infection is more severe when the coronavirus has originated in animals and spread to humans, as is the case with MERS and SARS. SARS-CoV-2 is a betacoronavirus, similar to MERS and SARS, both of which have their origins in bats. The animal source of SARS-CoV-2 has not yet been identified, however Chinese officials have linked many of the early cases to åa large seafood and live animal market, suggesting that the initial transmission was the result of animal-to-person spread. However, many of the later detected cases did not report any exposure to animal markets, indicating that the virus is now spreading via human-to-human contact.

Symptoms of infection with SARS-CoV-2 can range from milder symptoms such as a runny nose, sore throat, cough, and fever to more severe symptoms including pneumonia or breathing difficulties. In some cases infection with SARS-CoV-2 has resulted in death. As with other respiratory illnesses, older people and individuals with pre-existing medical conditions (such as diabetes or heart disease) are more vulnerable to becoming severely ill with the virus.

The Chinese authorities posted the full genome of SARS-CoV-2 on the NIH sequencing database GenBank. The CDC reported that the first cases of COVID-19 in the US that were sequenced are similar to the sequence published by China, therefore adding further evidence to the fact that there was a single, recent emergence of this virus from an animal source.

Accurate diagnosis of COVID-19 is through the use of real-time RT PCR (rRT-PCR) assays for the in vitro qualitative detection of SARS-CoV-2 in respiratory specimens and sera. The CDC has published full guidelines on their website for the collection, storage and handling of specimens, nucleic acid extraction, quality control, the rRT-PCT detection assay (including the probes and primers), and interpreting test results https://www.cdc.gov/coronavirus/2019-ncov/lab/rt-pcr-detection-instructions.html.

For further information related to SARS-CoV-2 and COVID-19 (formerly 2019-nCoV), please see the following links:

Centres for Disease Control and Prevention (CDC)
World Health Organization (WHO)